Rare Disease Therapeutics

ANASCORP

Manufacturer:

Rare Disease Therapeutics

Anascorp HCPCS:

J0716

HCPCS Code Descriptor:

Injection, centruroides immune f(ab)2, up to 120 milligrams

Category:

J Code

Anascorp NDCs:

66621-0150-02

Primary Type:

Antivenin

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Anascorp:

ANASCORP is an Antivenin drug manufactured by Rare Disease Therapeutics and administered via the Intravenous route of administration. The J Code: J0716 is aligned to the drug ANASCORP.

ACCESS PRICING AND MORE BY REGISTERING

J0716 Added Date:

January 1, 2013

J0716 Effective Date:

January 1, 2013

J0716 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Anascorp billing and coding information.
Our team did not identify a source for Anascorp patient assistance information. Please reach out to our team if you feel that this is a mistake.
ANASCORP prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ANASCORP. Please check back in a few weeks.